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Cardiovascular disease and 
global health: a perspective from 
the global South
BACKGROUND 
Global health simply refers to the health of populations in a global context. Global health has 
been defined as an “area of study, research and practice that focuses on improving health and 
achieving equity in health for all people worldwide”.(1) Scholarship in global health often focuses 
on worldwide health improvement, reduction of disparities, and protection against global threats 
that disregard national borders. Global health can be measured as a function of various global 
diseases and their prevalence in the world and threat to decrease life in the present day. 
Importantly, global health must not be confused with public health (defined as the science of 
protecting and improving the health of communities through education, policy making, health 
promotion and research for disease and injury prevention) or international health (defined as the 
branch of public health that focuses on low- and middle-income countries [LMICs] receiving 
foreign aid from high-income countries [HICs]). Table 1 shows the abbreviations. 
The predominant agencies associated with global health are the World Health Organisation 
(WHO) and the United Nations (UN). The UN has played a critical role in encouraging cross-
sectoral collaboration to address global health and its underlying socioeconomic determinants 
through the declaration of the Millennium Development Goals (MDGs) in 2000 (Figure 1), and 
more recently (2015), the Sustainable Development Goals (SDGs) (Figure 2).
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TABLE I: Abbreviations.
AIDS Acquired immunodefi ciency syndrome
CVD Cardiovascular disease
HICs High-income countries
LMICs Low- and middle-income countries
MDG Millennium Development Goals
NCDs Noncommunicable diseases
SDG Sustainable Development Goals
UHC Universal healthcare
UN United Nations













Inspired by unprecedented improvements in human health and development in recent decades, 
our world has embarked on a quest that only a generation ago would have been considered 
unreachable: achieving sustainable health and development for all.(2) Improving the health and 
wellbeing of the world's people is at the core of the SDGs, reflected in targets that call for ending 
the epidemics of acquired immunodeficiency syndrome (AIDS), tuberculosis, and malaria; 
achieving enormous improvements in maternal and child health; and tackling the growing burden 
of noncommunicable diseases (NCDs), particularly due to cardiovascular disease (CVD). 
Attaining universal health coverage (UHC) is the means by which these ambitious health targets 
are to be achieved.(2)
While SDGs may reflect an unprecedented level of global solidarity and resolve, the trends that 
increasingly define our world in 2020 are completely inconsistent with the spirit of the SDGs. The 
FIGURE 1: Millennium Development Goals.
FIGURE 2: Sustainable Development Goals.
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current coronavirus pandemic has exposed weaknesses in global health systems and governance 
and worsened disparities amongst countries as they compete for limited resources – including 
personal protective equipment and other medical technologies. We have witnessed flagrant 
racism against Africans in China and other parts of the world. SARS-CoV-2 infections have 
devastated economies leading to the loss of hundreds of millions of jobs globally and impacting 
negatively on the health of people who are unable to access medical care, particularly those 
with chronic conditions. Even before the social, economic and health crisis caused by COVID-19, 
we witnessed a retreat in democracy, with declining respect for civil society and human rights. 
Immediately after the launch of the SDGs, official development assistance for health stalled, as 
inward-looking nationalism displaced recognition of the need for global collaboration to address 
shared challenges. The loss of momentum on global health ignores the urgent need to strengthen 
health systems to address the steady growth of NCDs, which now account for 7 of 10 deaths 
worldwide.(2)
Sebastian Taylor argues that global health is increasingly a widely invoked and powerful discur-
sive construct. From an epidemiological perspective, global health may be characterised by 
health issues whose causes or redress lie outside the capability of any one nation state. From 
a globalisation perspective, fundamental neoliberal norms that underpin contemporary eco-
nomic globalisation – in particular, the imperative of growth, and the meaning of inequality and 
poverty – present profound challenges for global health. Comprehending global health requires 
a nuanced understanding of domestic policymaking within national government systems, the 
intersection of health with foreign, trade, development and security agendas and drawing on 
international relations theory, public policy, political science and institutional ethnography. 
Without proper governance, global health is emerging as “a new terrain on which older con-
tests – of ideological interpretation, geopolitical interest, empirical method – are played out. 
In its best form, global health offers real opportunities for more collective, equitable health 
thinking and action”.(3)
A HISTORY OF GLOBAL HEALTH
Global health is not a new discipline. Lessons learnt from the Broad street cholera outbreak in 
1854 were crucial to the understanding of disease epidemiology, applicable today. Microorga-
nisms causing malaria and tuberculosis were identified in 1880 and 1882, respectively. Discoveries 
of the Bacille Calmette-Guerin vaccine and penicillin in the 1920s and eradication of smallpox in 
1977 increased the expectation that many global diseases could be eradicated. Global 
collaboration in health, politics and economics was substantially increased with the establish-
ment of the UN and World Bank in 1945. Jan Smuts drafted the charters of the League of 
Nations and the UN. The WHO was founded in 1948 by member states of the UN. The WHO 
published its global list of essential medicine in 1978, and, in the same year, the Alma Ata 
declaration underlined the importance of primary healthcare as a global health approach. 
At the UN summit in 2000, the 8 MDGs were launched which reflected the major challenges 
facing human development globally. By 2015, it was clear that we had failed in the MDG quest, 
with health and economic disparities widening between the global North and global South, with 
many countries reporting regress on many of the MDG measures, and with corruption and civil 
unrest in the global South benefiting countries in the global North. In adopting the SDGs in 
2015, UN member states set the world on a quest without precedent in human history: SDGs 
elevate global health and development aspirations, and envision a world that is far more 
prosperous, far more secure, far more healthy, and far more equitable than it has ever been, 
where human rights and dignity are universally respected, and where human development 
unfolds in a manner that preserves and protects the natural environment.(2) Yet, by 2016, 
prospects for achieving many of these visionary aims had dimmed, as the world became more 















In the past 3 decades, global health has been firmly established as a discipline, with every major 
university in the global North establishing a global health institute. These institutes have partnered 
with universities and civil society groups in the global South. Yet, the investment in salaries, 
students trained, and papers published have almost largely benefited institutions in the global 
North, with few tangible benefits for the global South. This had led to a view of global health as 
being a new form of imperialism by countries in the global North. 
Many have argued that the coronavirus pandemic has starkly revealed the fallacy of global health. 
Many nations in the global South are drowning in debt with fragmented health systems ill-
equipped to respond to the challenges imposed by SARS-CoV-2 infections, while countries in 
the global North have been able to unlock trillions of dollars to build new hospitals and to keep 
economies alive. Similarly, in a country like South Africa with the highest Gini coefficient globally, 
there are endless examples of how the inequality between affluent and indigent members of 
our society has been flagrantly unmasked. 
GLOBAL HEALTH AND CARDIOVASCULAR DISEASE IN AFRICA
NCDs are the leading cause of death worldwide; and of these CVD is the leading cause of 
morbidity and mortality globally, accounting for 46.2% of NCD deaths.(4) Eighty five percent of all 
CVD-related deaths occur within LMICs.(4,5) Hypertension, cardiomyopathy, rheumatic heart 
disease and stroke account for most of this CVD mortality in sub-Saharan Africa (SSA).(5) Sub-
stantial resources and financial investments are required for the prevention and treatment of 
CVD, and many patients in LMICs are unable to access therapeutic strategies considered standard 
of care in HICs.(6) SSA has 15% of the world’s population and yet accounts for 1% of the global 
expenditure on healthcare. The rapid population growth driven by decreasing mortality and high 
fertility will change Africa’s population pyramid and will have far-reaching implications for disease 
burden and provision of healthcare, in particular for CVD. Hence, multiple calls have been made 
for CVD to rise in priority on the global health agenda.(7) The WHO and many other societies 
have emphasised the need for global health research, particularly in CVD. 
The need for CVD researchers and healthcare workers in SSA does not match the workforce 
capacity at present. Research and fellowships by academics and postgraduate students from 
the global North have tended to fill this void, with no clear benefits for health systems in many 
African countries. It is imperative that countries in SSA articulate their own priorities and 
strategies for dealing with prevalent CVD, rather than having these imposed upon them by 
individuals and institutions in the global North. A major challenge is that most funding for research 
and programmatic approaches comes from countries in the global North, and the requests 
for applications often speak to the interests and strategic priorities of these countries. There-
fore, African governments and industry also need to contribute to driving scholarship with an 
African agenda.
Global health in cardiology needs to be understood in the context of current global cardiovas-
cular health priorities. Significant barriers to estimation of CVD exist in SSA, including the lack 
of vital registration systems in most countries. Modelled estimates based on available verbal 
autopsy and vital registration data suggest higher rates of CVD in eastern and central SSA in 
comparison with western and southern SSA, although the uncertainty intervals are wide. In 
general, verbal autopsy data suggest that 9 - 13% of deaths are attributable to CVD. Stroke, 
hypertensive heart disease and cardiomyopathy represent a much larger proportion of total 
death than in other regions of the world. Reflecting higher all-cause mortality and shorter lifespans 
overall, the mean age of death attributable to CVD in SSA in 2010 was the youngest in the world 
at 64.9 years, compared with 67.6 - 81.2 years for the rest of the world.(8) Table 2 shows some 
of the key gaps in knowledge that need immediate answers in order to plan evidence-based 
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TABLE II: Key challenges, knowledge gaps and research priorities in SSA.
Limited data on disease epidemiology and 
burden of disease.
Urgently need population-based studies; need to decrease reliance on hospital-based data.
Limited data on variation in cardiovascular 
risk factors.
Need expansion of household health examination surveys, with wider sharing of results; need broader 
collection of anthropometric and biomarker data including blood pressure, glycosylated haemoglobin and 
cholesterol levels; need renewed efforts for population-based surveillance of CVD events, including myocardial 
infarction and stroke.
Limited data on cardiovascular disease 
outcomes.
Need longitudinal/cohort studies to assess CVD outcomes from different diseases amongst Africans; need 
more studies on determinants of outcomes for CVD in Africa.
Limited data on mortality from cardiovascular 
disease, particularly in the poorest regions.
Need increased national investment in sample and comprehensive vital registration systems; need sharing of 
best practices for data collection and verbal autopsy; need more efforts to improve ascertainment of death.
Limited data on optimal strategies for 
cardiovascular disease management.
Greater need for national and regional registries and randomised controlled studies to test different therapies 
for CVD in Africans.
Limited data on cost-effectiveness of 
interventions.
Need studies on cost-effectiveness of various interventions on CVD, particularly those focused on primary 
healthcare.
Changes in cardiovascular mortality are more 
complex than suggested by a stepwise model 
of epidemiological transition.
National health planning needs to consider a broad range of contextual factors, including local patterns of risk, 
policies that infl uence health, and current health system arrangements; need formal CVD costing studies in 
LMIC to address fi nancial risk and health system effi ciencies; need improved cross-cultural measures of 
disability related to CVD.
Poor coordination of various sources of data.
Need more population and health information in the public domain; need better governmental, international 
and intersectoral collaboration on coordination of different sources of data needed to inform health 
strategies; need different types of data on CVD including household surveys, census, health facility data, disease 
surveillance data, population health studies, policy data and research studies.
Infrequent analysis of population health data.
Ministries of Health in African countries need to conduct periodic health programme reviews to establish 
whether policies are producing the desired results; need to regularly undertake assessments of incidence, 
distribution and control of CVD; need frequent analysis of collected data; need coordinated and systematic 
analysis and review of existing data at regular intervals.
Poor quality data structures.
Need to ensure suffi cient complexity of data with periodic population, register and health surveys consisting 
of quantitative, qualitative and geospatial data that is voluminous and comprehensive, requiring well-trained 
staff with appropriate analytical skills.
Poor data quality
Need to strengthen health systems; need to improve accuracy, timing, utility of data; need to improve analytic 
capacity; need to minimise missing data points and errors in data entry and computation; need to minimise 
errors leading to wrong results, wrong conclusions and wrong recommendations; need to strengthen national 
statistics offi ces.
High costs of data collection, handling, 
archiving and analysis.
Need statistical offi ces with necessary technological, fi nancial and human resource capacities to collect, 
process and disseminate required data in a timely fashion.
Limited funding to support research from 
African governments.
African governments must consider ring-fencing 1 - 2% of their GDPs to support collection and curation of 
health data; need greater domestic budgets for CVD research; need to trial pay-for-performance agreements 
with donor funding; consider public–private partnerships.
Suboptimal use of existing technologies to 
enhance data collection, coordination, 
architecture, quality and cost.
Need appropriate use of existing technologies to enhance utility of existing data to inform policies













interventions. Africa-specific data are needed to inform, to plan policy making, for accurate 
decision-making, for cost-efficiency, to reduce risk and for agility in health systems. 
Global health is important in cardiology as international collaboration on research and pro-
grammatic approaches is increasingly the norm. In addition, the ease of international travel has 
made it possible for many cardiology fellows to train in other parts of the world, but also for 
individuals with cardiovascular disease to present in clinics all over the world. Increasingly, the 
importance of nurturing a cadre of cardiology providers who can prevent and treat cardiovas-
cular diseases in international settings is recognised. Furthermore, forming new global cardio-
vascular disease research collaborations may lead to collaborative problem solving and 
development – forming such global cardiovascular research and mentorship relationships as a 
trainee provides one with a broader network of collaborators at a critical time in the transi-
tion to an academic early-career cardiologist. However, such opportunities for training and 
fellowships in global cardiovascular health have largely benefited students from HICs, as relatively 
few students from LMICs are able to afford and take up opportunities for exchange.
It has been stated that global health training and exposure engenders humility, empathy and 
respect in building trust with patients amongst trainees. 
There is an urgent need for the establishment of more African institutes of research to set 
priorities and lead programmes of scholarship on African cardiovascular epidemiology, population 
health, basic science, clinical investigation and randomised clinical trials for optimal therapeutic 
approaches. There is also a greater need for collaboration between scientists on the African 
continent to work collaboratively to solve Africa’s fundamental challenges. 
In this issue of the Journal, we continue our collaboration with the European Society of Cardiology 
on key publications in 2019 in the European Heart Journal. A review and summary of key pub-
lications related to acute coronary syndromes,(9) coronary interventions,(10) aorta and peripheral 
circulation,(11) and arrhythmia and pacing(12) are included in this issue. This issue also contains 
pieces on establishing new clinical centres, valvular heart disease, pericardial disease and endo-
myocardial fibrosis, all which have substantial relevance for cardiovascular global health in Africa.
Enjoy reading.
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